Takeover

Announcement of Date of Scheme Court Hearing to Sanction Scheme

Retrieved on: 
Monday, May 30, 2022
Part, Knowledge, Telephone, PRA, Central Bank of Ireland, Takeover, K.G.F: Chapter 1, Financial Conduct Authority, Person, EGM, High Court, Goodbody Stockbrokers, Ownership, Acquisition, United Kingdom, Company, Prudential Regulation Authority (United Kingdom), Irish Takeover Panel, Credit Suisse International v Stichting Vestia Groep, Court, British Virgin Islands company law, Central bank, Scheme, Sale, Prudential regulation, Act, Court of cassation, Trustee, Four Courts, Credit Suisse, Documentation, Real estate, Mail, Property management, Hibernia REIT, Goodbody

Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the scheme document published by Hibernia REIT on 27 April 2022.

Key Points: 
  • Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the scheme document published by Hibernia REIT on 27 April 2022.
  • Under the provisions of Rule 8.3 of the Takeover Rules, if any person is, or becomes, interested (directly or indirectly) in, 1 per cent.
  • This requirement will continue until the date on which the offer period ends.
  • Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction.

Quidel and Ortho Announce Expected Closing of Ortho Transaction

Retrieved on: 
Thursday, May 26, 2022
Form, Registrar of Companies, Food, U.S. Securities and Exchange Commission, SVC, Antibody, UK, Blood, YouTube, Terminology, Private Securities Litigation Reform Act, Twitter, Laboratory, JOINT, City Code on Takeovers and Mergers, Mergers and acquisitions, Nature, COVID-19, Failure, SAN, Food and Drug Administration, Facebook, Youth justice in England and Wales, Attention, Hospital, GLOBE, Part, Infection, Health, IVD, FDA, Efficiency, Communication, THE, LinkedIn, HIV, Security (finance), Telephone, Takeover, Patient, NASDAQ, High Court, Drug Master File, Hepatitis C, Commission, TO, Linear code, Medical device, Vaccine, Risk management, Quidel Corporation, Ortho, Nasdaq, Topco

Shares of Quidel and Ortho will cease trading after the market close on May 26, 2022, and following the closing, Ortho will no longer be listed on Nasdaq.

Key Points: 
  • Shares of Quidel and Ortho will cease trading after the market close on May 26, 2022, and following the closing, Ortho will no longer be listed on Nasdaq.
  • Under the terms of the agreement governing the transaction, Ortho shareholders will receive $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho common share.
  • Quidel stockholders will receive one share of QuidelOrtho common stock for each share of Quidel common stock.
  • Each of Quidel and Ortho commenced mailing copies of the definitive joint proxy statement/prospectus to stockholders of Quidel and Ortho, respectively, on or about April 11, 2022.

Quidel and Ortho Announce Expected Closing of Ortho Transaction

Retrieved on: 
Thursday, May 26, 2022
Technology, Research, Infectious Diseases, Clinical Trials, Health, Pharmaceutical, General Health, Data Management, Science, Form, Registrar of Companies, Food, U.S. Securities and Exchange Commission, SVC, Antibody, UK, Blood, YouTube, Terminology, Private Securities Litigation Reform Act, Twitter, Laboratory, JOINT, City Code on Takeovers and Mergers, Mergers and acquisitions, Nature, COVID-19, Failure, Food and Drug Administration, Facebook, Youth justice in England and Wales, Attention, Hospital, Part, Infection, Health, IVD, FDA, Efficiency, Communication, THE, LinkedIn, HIV, Security (finance), Telephone, Takeover, Corporation, Patient, NASDAQ, High Court, Drug Master File, Hepatitis C, Commission, TO, Linear code, Medical device, Vaccine, Risk management, Quidel Corporation, Ortho, Nasdaq, Topco

Shares of Quidel and Ortho will cease trading after the market close on May 26, 2022, and following the closing, Ortho will no longer be listed on Nasdaq.

Key Points: 
  • Shares of Quidel and Ortho will cease trading after the market close on May 26, 2022, and following the closing, Ortho will no longer be listed on Nasdaq.
  • Under the terms of the agreement governing the transaction, Ortho shareholders will receive $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho common share.
  • Quidel stockholders will receive one share of QuidelOrtho common stock for each share of Quidel common stock.
  • Each of Quidel and Ortho commenced mailing copies of the definitive joint proxy statement/prospectus to stockholders of Quidel and Ortho, respectively, on or about April 11, 2022.

Results of Scheme Meeting and EGM

Retrieved on: 
Tuesday, May 24, 2022
Knowledge, Telephone, PRA, Central Bank of Ireland, Takeover, Financial Conduct Authority, Person, High Court, Goodbody Stockbrokers, Ownership, Acquisition, Condition, United Kingdom, Prudential Regulation Authority (United Kingdom), Irish Takeover Panel, Credit Suisse International v Stichting Vestia Groep, Court, Court of cassation, Central bank, Name, Scheme, Sale, Prudential regulation, Trustee, Credit Suisse, Documentation, Holding company, Mail, Property management, Project Panther Bidco, Hibernia REIT, Goodbody

Completion of the Acquisition remains subject to satisfaction or waiver of the other Conditions set out in the Scheme Document including the sanction by the High Court of the Scheme at the Court Hearing.

Key Points: 
  • Completion of the Acquisition remains subject to satisfaction or waiver of the other Conditions set out in the Scheme Document including the sanction by the High Court of the Scheme at the Court Hearing.
  • It is expected that an application will shortly be made to the High Court to fix the date of the Court Hearing to sanction the Scheme on a date in June 2022.
  • Once this date has been fixed, Hibernia REIT will give notice of this date by issuing an announcement through a Regulatory Information Service.
  • Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the Scheme Document.

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

Retrieved on: 
Monday, May 16, 2022
Technology, Medical Devices, Infectious Diseases, Other Technology, Biotechnology, Other Health, Health, General Health, Data Management, Part, Telephone, Form, Takeover, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, SVC, Corporation, Nasdaq, City Code on Takeovers and Mergers, Infection, Patient, Topco, High Court, SEC filing, Mergers and acquisitions, Nature, Commission, COVID-19, Failure, FDA, UK, TO, Youth justice in England and Wales, Court, Attention, Communication, Terminology, THE, Linear code, England, Acquisition, Security (finance), JOINT, Annual report, Risk management, Quidel Corporation, Ortho

Quidel Corporation (Nasdaq: QDEL) (Quidel), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc (Ortho) by Quidel and subsequent business combination were approved by Quidels stockholders at Quidels Special Meeting on May 16, 2022.

Key Points: 
  • Quidel Corporation (Nasdaq: QDEL) (Quidel), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc (Ortho) by Quidel and subsequent business combination were approved by Quidels stockholders at Quidels Special Meeting on May 16, 2022.
  • Under the terms of the agreement by which Quidel will acquire Ortho, Ortho shareholders will receive $7.14 in cash and 0.1055 shares of the combined company common stock for each Ortho common share.
  • In connection with the proposed business combination transaction among Quidel, Ortho and Coronado Topco, Inc. (Topco), Topco has filed a registration statement on Form S-4 (File No.
  • Each of Quidel and Ortho commenced mailing copies of the definitive joint proxy statement/prospectus to stockholders of Quidel and Ortho, respectively, on or about April 11, 2022.

Information regarding Scheme Meeting and Extraordinary General Meeting

Retrieved on: 
Thursday, May 12, 2022
Knowledge, Telephone, Company, PRA, Central Bank of Ireland, Takeover, Financial Conduct Authority, Person, EGM, AGM, Goodbody Stockbrokers, Ownership, Acquisition, United Kingdom, Prudential Regulation Authority (United Kingdom), Irish Takeover Panel, Credit Suisse International v Stichting Vestia Groep, Court, Central bank, Registrar, Name, Scheme, Sale, Prudential regulation, Windmill Lane Studios, Trustee, Address, Credit Suisse, Documentation, Security (finance), Mail, Property management, Project Panther Bidco, Hibernia REIT, Goodbody

The Scheme Meeting will start at 11.15 a.m. (Dublin time) and the EGM will start at 11.30 a.m. (Dublin time) (or, if later, as soon thereafter as the Scheme Meeting, convened for the same date and place, has concluded or has been adjourned).

Key Points: 
  • The Scheme Meeting will start at 11.15 a.m. (Dublin time) and the EGM will start at 11.30 a.m. (Dublin time) (or, if later, as soon thereafter as the Scheme Meeting, convened for the same date and place, has concluded or has been adjourned).
  • While both the Scheme Meeting and the EGM are physical meetings, the Company is providing a two-way teleconferencing facility for Shareholders to listen to the business of the Scheme Meeting and/or EGM, as well as ask questions or raise points related solely to the business of the relevant meeting, remotely.
  • For the avoidance of doubt, this teleconferencing facility will only allow Shareholders to listen to the business of the Scheme Meeting and/or EGM and/or to raise questions or points related solely to the business of the relevant meeting questions.
  • It will not allow Shareholders to vote at the Scheme Meeting or EGM or be counted in the quorum for the relevant meeting.

Announcement relating to approval by the Competition and Consumer Protection Commission

Retrieved on: 
Friday, April 29, 2022
Sale, Central Bank of Ireland, Credit Suisse, FCA, Name, Ownership, Court, Documentation, Person, United Kingdom, Australian Prudential Regulation Authority, Financial Conduct Authority, Company, Trustee, Scheme, Takeover, Telephone, EGM, Irish Takeover Panel, Consumer Protection Committee, CCPC, Competition, Central bank, Goodbody Stockbrokers, Condition, Competition and Consumer Protection Commission, Prudential regulation, Knowledge, PRA, Acquisition, Credit Suisse International v Stichting Vestia Groep, Real estate, Life insurance, Bank, Mail, Hibernia REIT, Project Panther Bidco, Goodbody

The Competition and Consumer Protection Commission (the "CCPC") has now made its determination in respect of the Acquisition and has concluded that it may be put into effect.

Key Points: 
  • The Competition and Consumer Protection Commission (the "CCPC") has now made its determination in respect of the Acquisition and has concluded that it may be put into effect.
  • Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the Scheme Document.
  • The Hibernia REIT Directors accept responsibility for the information contained in this announcement relating to Hibernia REIT, the Hibernia REIT Group and the Hibernia REIT Directors and members of their immediate families, related trusts and persons connected with them.
  • Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction.

Announcement relating to despatch of Rule 15 Proposal

Retrieved on: 
Wednesday, April 27, 2022
Sale, Project Panther Bidco, Letter, Ownership, Court, Documentation, Person, United Kingdom, Trustee, Scheme, Proposal, Takeover, Acquisition, Telephone, Irish Takeover Panel, REIT, Knowledge, Real estate, Online shopping, Mail, Hibernia REIT

The Proposal is being made available for inspection on Hibernia REIT's website at https://www.hiberniareit.com/ and Bidco's website at https://www.benedict-offer.com/.

Key Points: 
  • The Proposal is being made available for inspection on Hibernia REIT's website at https://www.hiberniareit.com/ and Bidco's website at https://www.benedict-offer.com/.
  • For the avoidance of doubt, the content of such websites is not incorporated into, and does not form part of, this announcement.
  • If you are a Hibernia REIT Awardholder and did not receive the Proposal, please contact Sean O'Dwyer at Hibernia REIT at [email protected].
  • The Hibernia REIT Directors accept responsibility for the information contained in this announcement relating to Hibernia REIT, the Hibernia REIT Group and the Hibernia REIT Directors and members of their immediate families, related trusts and persons connected with them.

Announcement relating to timing of publication of Scheme Document

Retrieved on: 
Thursday, April 21, 2022
FCA, PRA, Financial Conduct Authority, British Virgin Islands company law, Takeover, Telephone, Central Bank of Ireland, Part, Scheme, Credit Suisse International v Stichting Vestia Groep, Documentation, Trustee, Central bank, Goodbody Stockbrokers, Announcement, Sale, Ownership, Person, Prudential Regulation Authority (United Kingdom), Company, United Kingdom, 1997 Constitution of Fiji: Chapter 1, Irish Takeover Panel, Panel on Takeovers and Mergers, Prudential regulation, Act, Credit Suisse, Knowledge, Real estate, Bank, Mail, Hibernia REIT, Goodbody, Court, Acquisition

It is expected, subject to Court directions in relation to the convening of the scheme meeting having been previously received, that the Scheme Document will be published on or around 27 April 2022.

Key Points: 
  • It is expected, subject to Court directions in relation to the convening of the scheme meeting having been previously received, that the Scheme Document will be published on or around 27 April 2022.
  • The Company anticipates that the scheme meeting (and related extraordinary general meeting) will be convened to be held before the end of May 2022.
  • Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the Announcement.
  • Further details in relation to Overseas Shareholders will be contained in the Scheme Document.

Sodexo and the Humane Society of the United States Team up to Tackle Climate Change with Plant-based Meals

Retrieved on: 
Tuesday, April 19, 2022
Innova, Water, Health, Government, Carbon, Climate change, Faculty, Fortune 500, Twitter, Student, Hunger, HSUS, YouTube, GLOBE, Education, Program, LinkedIn, RDN, Humanity (virtue), Volunteering, Animal, Humane society, Takeover, Instagram, Safety, Industry, Quality of life, Brothers in Unity, University, Renewable energy, Agriculture, Restaurant, Sodexo, Facebook

The new initiatives focus on increasing plant-based menu options that will end up on Sodexo menus at hundreds of universities across the United States.

Key Points: 
  • The new initiatives focus on increasing plant-based menu options that will end up on Sodexo menus at hundreds of universities across the United States.
  • Overall, Sodexo is committed to serving plant-based meals wherever and whenever possible in an effort to reduce the impacts of climate change.
  • Founded in 1954, the Humane Society of the United States fights the big fights to end suffering for all animals.
  • We fight all forms of animal cruelty to achieve the vision behind our name: A humane society.